KIMBERLY BOLLMEIER: Open Payments
NPI 1598023939 · DELAFIELD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 50 payments from 14 companies in 2025. Trend: 2023 $1,123 · 2024 $1,573 · 2025 $1,216
Food & beverage: $1,131Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $287 |
| Galderma Laboratories, L.P. | 9 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $157 |
| UCB, Inc. | 5 | $101 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Lilly USA, LLC | 4 | $79 |
| Amgen Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| ABBVIE INC. | 2 | $48 |
| Botanix SB Inc | 2 | $34 |
Products named: DUPIXENT, Bimzelx, TALTZ, ILUMYA, OTEZLA, COSENTYX, SKYRIZI, SOFDRA.
Industry payments across WI — which companies pay providers there.
